Casdin Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
9
- Investments
-
258
- Portfolio
-
87
- Exits
-
106
Casdin Capital General Information
Company Description
Founded in 2012, Casdin Capital is a venture capital firm based in New York, New York. The firm seeks to invest in the life sciences, oncology, digital health, agtech, and healthcare sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.casdincapital.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 1350 Avenue of the Americas
- Suite 2600
- New York, NY 10019
- United States
Casdin Capital Investments (258)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Leyden Labs | 09-Jan-2025 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| nChroma Bio | 05-Dec-2024 | Biotechnology | Generating Revenue | |||
| Maze Therapeutics | 26-Nov-2024 | Drug Discovery | Profitable | |||
| Neurogene | 05-Nov-2024 | Drug Discovery | Generating Revenue | |||
| IDRx | 05-Aug-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| TMRW Life Sciences | 24-Jul-2024 | Other Devices and Supplies | Generating Revenue | |||
| Scorpion Therapeutics | 16-Jul-2024 | Drug Discovery | Generating Revenue | |||
| Xcell Biosciences | 14-Jun-2024 | Discovery Tools (Healthcare) | Generating Revenue | |||
| Septerna | 24-May-2024 | Early Stage VC | Drug Discovery | Generating Revenue/Not Profitable | ||
| BridgeBio Oncology Therapeutics | 30-Apr-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 |
Casdin Capital Exits (106)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Fabric Genomics | 07-May-2025 | Merger/Acquisition | |
| AmplifyBio | 07-Apr-2025 | ||
| PanTHERA CryoSolutions | 07-Apr-2025 | ||
| Notch Therapeutics | 31-Mar-2025 | ||
| IDRx | 21-Feb-2025 | ||
| Maze Therapeutics | 31-Jan-2025 | ||
| SeQure DX | 29-Jan-2025 | ||
| Molecular Assemblies | 28-Jan-2025 | ||
| Chroma Medicine | 04-Dec-2024 | Merger/Acquisition | |
| Septerna | 25-Oct-2024 | IPO |
Casdin Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Casdin Capital Co-Investors (544)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| GV | 24 |
|
|
||
| Alexandria Venture Investments |
|
|
|||
| ARCH Venture Partners |
|
|
|||
| Andreessen Horowitz |
|
|
|||
| S32 |
|
|
Casdin Capital FAQs
-
What is Casdin Capital?
Founded in 2012, Casdin Capital is a venture capital firm based in New York, New York.
-
When was Casdin Capital founded?
Casdin Capital was founded in 2012.
-
Where is Casdin Capital headquartered?
Casdin Capital is headquartered in New York, NY.
-
What is Casdin Capital's total asset value?
Casdin Capital has around in total assets under management.
-
How many investments has Casdin Capital made?
Casdin Capital has made 258 investments.
-
What has Casdin Capital invested in?
Casdin Capital has made numerous investments in companies like Leyden Labs, nChroma Bio, and Maze Therapeutics within the Drug Discovery and Biotechnology industries.
-
What has Casdin Capital invested in recently?
Casdin Capital's latest investment was on 09-Jan-2025 in Leyden Labs, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
